Literature DB >> 7438123

Vindesine chemotherapy in lung cancer.

R B Natale, R J Gralla, R E Wittes, R B Golbey, C W Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7438123     DOI： 10.1016/s0305-7372(80)80009-0

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

1.  Twice weekly vindesine, a phase II study in lung cancer.

Authors:  P E Postmus; N H Mulder; D L Schipper; E G de Vries
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 2.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

4.  Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer.

Authors:  S G Allan; A Gregor; M A Cornbleet; R C Leonard; J F Smyth; I W Grant; G K Crompton
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.

Authors:  R Pazdur; A H Rossof; G Chandra; P D Bonomi; R E Slayton; J Wolter
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.